MOTHAFFAR RIMAWI to Neoplasms, Second Primary
This is a "connection" page, showing publications MOTHAFFAR RIMAWI has written about Neoplasms, Second Primary.
Connection Strength
0.186
-
Margetuximab in HER2-positive metastatic breast cancer. Future Oncol. 2023 May; 19(16):1099-1112.
Score: 0.186
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.